Abstract
Nearly two thirds of persons suspected of having tickborne illness in central North Carolina, USA, were not tested for Ehrlichia. Failure to test may have resulted in a missed diagnosis for ≈13% of these persons, who were therefore substantially less likely to receive antimicrobial treatment and to have follow-up testing performed.
Keywords:
Ehrlichia; North Carolina; Rickettsia; Tick; USA; United States; bacteria; tickborne diseases; vector-borne infections.
Publication types
-
Research Support, N.I.H., Extramural
MeSH terms
-
Adult
-
Aged
-
Animals
-
Anti-Bacterial Agents / therapeutic use
-
Arachnid Vectors / microbiology*
-
Cohort Studies
-
Demography
-
Doxycycline / therapeutic use
-
Ehrlichia / immunology*
-
Ehrlichia / isolation & purification
-
Ehrlichiosis / diagnosis*
-
Ehrlichiosis / drug therapy
-
Ehrlichiosis / epidemiology
-
Ehrlichiosis / microbiology
-
Female
-
Humans
-
Ixodidae / microbiology*
-
Male
-
Middle Aged
-
North Carolina / epidemiology
-
Retrospective Studies
-
Seroepidemiologic Studies
-
Tick-Borne Diseases / diagnosis*
-
Tick-Borne Diseases / drug therapy
-
Tick-Borne Diseases / epidemiology
-
Tick-Borne Diseases / microbiology
Substances
-
Anti-Bacterial Agents
-
Doxycycline